Pacemaker prevents fainting among select patient population
A select number of patients who suffer from neurally mediated synope (NMS) a disorder in which the brain fails to regulate heart rate and blood pressure may be good candidates to receive a dual-chamber pacemaker to prevent common NMS-related fainting spells, according to research presented today at the American College of Cardiology's 61st Annual Scientific Session. The Scientific Session, the premier cardiovascular medical meeting, brings cardiovascular professionals together to further advances in the field.
NMS is often benign; however, some patients have few, if any, warning signs or symptoms before an impending attack, which can result in repeated falls and make tasks like driving or operating machinery dangerous.
The use of cardiac pacing to prevent fainting has been controversial: two earlier studies have shown that pacemakers do not benefit patients who suffer from NMS because of severe hypotensive reflex, or a dramatic drop in blood pressure upon standing or tilting. Unlike these, the present Third International Study on Syncope of Uncertain Etiology (ISSUE-3) trial looked at the use of pacemakers among older patients who had severe asystolic NMS, which is not affected by fluctuations in blood pressure. Among these patients, a pacemaker reduced the relative risk of suffering another fainting episode by 57 percent.
"We found that approximately one out of three pacemaker patients will benefit from pacing therapy within the subsequent two years," said Michele Brignole, MD, head of cardiology at the Arrhythmologic Centre, Ospedali Tigullio in Lavagna, Genoa and the study's lead investigator. "Cardiac pacing therapy is effective in reducing syncopal recurrences in this highly selected population."
The study took place in 51 centers, and involved 511 patients over age 40 who had suffered more than three NMS episodes in the previous two years. Doctors used an implantable loop recorder (ILR), a device that acts like a mini-EKG, to record and determine the cause of fainting. Of the 511 patients, 77 of them had a spontaneous asystolic syncope and were implanted with a pacemaker that was randomly selected to the "on" or "off" position. The study's endpoint was fainting reoccurrence.
Fifty-seven percent of the patients who had pacemakers set to the "off" position had a fainting reoccurrence within two years, but only 25 percent of patients with an activated pacemaker suffered a syncope.
As researchers continue to study asystolic fainting, pacemakers may be useful for patients whose NMS impedes daily life and is very unpredictable.
"We estimate that approximately 40 percent of ISSUE-3-like patients receiving an ILR will eventually be candidates for pacemaker therapy within four years," Dr. Brignole said. Dr. Brignole said that younger patients with NMS often suffer a more benign form of the disorder and respond to less drastic treatments, like physical counter-pressure maneuvers.
"The fact that pacing is effective does not mean that it is also always necessary," Dr. Brignole added.
"Cardiac pacing should be a last choice in highly selected patients affected by severe NMS."
Dr. Brignole said a better measurement of a pacemaker's effectiveness would be a study that uses the long-term syncope burden, not the first syncope occurrence, as a study endpoint.
Provided by
American College of Cardiology
-
iPods may cause pacemaker glitch
May 12, 2007 |
not rated yet |
0
-
Danish trial demonstrates benefits of dual-chamber pacing in treating sick sinus syndrome
Aug 31, 2010 |
not rated yet |
0
-
Pacemaker implantation for heart failure does not benefit nearly half of the patients
Jun 13, 2011 |
not rated yet |
0
-
Study shows fainting factor in cardiac arrests
Feb 09, 2012 |
not rated yet |
0
-
Researchers find cardiac pacing helps epilepsy patients with ictal asystole
Mar 23, 2011 |
not rated yet |
0
-
Motion perception revisited: High Phi effect challenges established motion perception assumptions
Apr 23, 2013 |
3 / 5 (2) |
2
-
Anything you can do I can do better: Neuromolecular foundations of the superiority illusion (Update)
Apr 02, 2013 |
4.5 / 5 (11) |
5
-
The visual system as economist: Neural resource allocation in visual adaptation
Mar 30, 2013 |
5 / 5 (2) |
9
-
Separate lives: Neuronal and organismal lifespans decoupled
Mar 27, 2013 |
4.9 / 5 (8) |
0
-
Sizing things up: The evolutionary neurobiology of scale invariance
Feb 28, 2013 |
4.8 / 5 (10) |
14
-
The Durability of Bone: Long Falls
5 hours ago
-
Is energy convertible to matter?
7 hours ago
-
Rotating electron as a dipole is this right?
9 hours ago
-
Dipole term in multipole expansion
13 hours ago
-
Bubbles in a Pre-Boiling/Boiling pot of water
14 hours ago
-
Assumptions of Griffith's fracture theory
May 21, 2013
- More from Physics Forums - Classical Physics
More news stories
Biodegradable stent proves non-inferior to drug-eluting stent
The Orsiro stent, which is a novel stent platform eluting sirolimus from a biodegradable polymer, demonstrated non-inferiority to the Xience Prime everolimus-eluting stent for the primary angiographic endpoint of in-stent ...
Cardiology
10 hours ago |
5 / 5 (1) |
0
Post-approval TAVI registry shows high rates of device success at one year
One-year results from SOURCE XT – one of the largest, post-approval transcatheter aortic valve implantation (TAVI) registries to-date – reported today at EuroPCR 2013 show good clinical outcomes in routine clinical practice, ...
Cardiology
10 hours ago |
not rated yet |
0
Antidepressant reduces stress-induced heart condition
A drug commonly used to treat depression and anxiety may improve a stress-related heart condition in people with stable coronary heart disease, according to researchers at Duke Medicine.
Cardiology
11 hours ago |
5 / 5 (1) |
0
|
Study identifies superior hypertension treatment, efficacy between sexes
(Medical Xpress)—In a recent subgroup analysis of the largest blood pressure treatment trial in history, University of Alabama at Birmingham (UAB) researchers found that women and men react the same to ...
Cardiology
19 hours ago |
5 / 5 (1) |
0
Evaluating a new way to open clogged arteries
Over the past few decades, scientists have developed many devices that can reopen clogged arteries, including angioplasty balloons and metallic stents. While generally effective, each of these treatments ...
Cardiology
20 hours ago |
4.7 / 5 (6) |
0
|
If you can remember it, you can remember it wrong
(Medical Xpress)—Native peoples in regions where cameras are uncommon sometimes react with caution when their picture is taken. The fear that something must have been stolen from them to create the photo ...
B vitamins could delay dementia
(Medical Xpress)—Despite spending billions of dollars on research and development, drug companies have been unable to come up with effective treatments for dementia and Alzheimer's Disease (AD). Now, A. ...
Insight into the dazzling impact of insulin in cells
Australian scientists have charted the path of insulin action in cells in precise detail like never before. This provides a comprehensive blueprint for understanding what goes wrong in diabetes.
New sleeping pill poised to hit US markets
An experimental sleeping pill from US drug company Merck is effective at helping people fall and stay asleep, according to reviewers at the US Food and Drug Administration, which could soon approve the new drug.
Reducing caloric intake delays nerve cell loss
Activating an enzyme known to play a role in the anti-aging benefits of calorie restriction delays the loss of brain cells and preserves cognitive function in mice, according to a study published in the May ...
Drugs found to both prevent and treat Alzheimer's disease in mice
Researchers at USC have found that a class of pharmaceuticals can both prevent and treat Alzheimer's Disease in mice.